NK cell-mediated cytotoxicity modulation by A(2) adenosine receptor agonist in different mammalian species.

Abstract

Adenosines, endogenous purine nucleosides, appear in the extracellular space under metabolically stressful conditions associated with ischemia, inflammation, and cell damage. Their activity on innate immunity is prevalently inhibitory and can develop both in infectious and neoplastic diseases. During cancer development, tumor cells that release high concentrations of adenosines can impair the function of tumor-infiltrating lymphocytes and assist tumor growth by neo-angiogenesis. We evaluated the influence of A(2) adenosine receptor (A(2)AR) agonist on cytotoxic-cell response comparing human with other mammalian species (rodents, pigs, goats), both in healthy and in cancer conditions. The A(2)AR agonist developed dose-dependent inhibition of the cytotoxic activity of immune effector cells in all studied species. However, variability of the response was observed in relation to the species and the target cells that were used. Altogether, our data indicate that the A(2)AR plays a central role in adenosine-mediated inhibition of immune response to tumors.

• Authors: M Kuldová, J Svoboda, F Kovárů, L Vannucci, H Kovárů, A Fiserová
• Journal: Folia microbiologica (Folia Microbiol (Praha)) Vol. 54 Issue 4 Pg. 364-8 ( 2009) ISSN: 1874-9356 [Electronic] United States
• PMID: 19826926 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Adenosine A2 Receptor Agonists
• Receptors, Adenosine A2
• N-cyclopropyl adenosine-5'-carboxamide
• Adenosine

Topics

• Adenosine (analogs & derivatives, immunology, pharmacology)
• Adenosine A2 Receptor Agonists
• Animals
• Cells, Cultured
• Cytotoxicity, Immunologic (drug effects)
• Female
• Goats
• Humans
• Killer Cells, Natural (drug effects, immunology)
• Male
• Mice
• Mice, Inbred C57BL
• Neoplasms (immunology)
• Rats
• Rats, Wistar
• Receptors, Adenosine A2 (immunology)
• Rodentia
• Swine